z-logo
Premium
Successful application of indirect in‐situ polymerase chain reaction to tissues fixed in Bouin's solution
Author(s) -
Li Vigni R,
Bianchi U A,
Carosi G,
Lomini M,
Falchetti M,
Callea F,
Pecorelli S
Publication year - 1999
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1046/j.1365-2559.1999.00698.x
Subject(s) - polymerase chain reaction , in situ hybridization , human papillomavirus , in situ , typing , pathology , biology , cervical intraepithelial neoplasia , medicine , virology , chemistry , cervical cancer , gene , messenger rna , cancer , genetics , organic chemistry
Aims To evaluate the value of polymerase chain reaction‐in situ hybridization (PCR‐ISH) for the detection of human papillomaviruses (HPV) in paraffin sections of cervical biopsies fixed either in 10% formalin or in Bouin's solution. Methods and results We analysed 40 biopsies from Italian women infected with the human immunodeficiency virus type 1 (HIV 1). In‐situ hybridization techniques were performed with commercial biotinylated probes. The PCR‐ISH was carried out by the ‘hot start modification’. Cervical intraepithelial neoplasia (CIN) was found in 23 of 40 patients (57.5%); eight cases showed condylomatous features. Human papillomavirus was detected in 42.5% by ISH and in 65% by PCR‐ISH. Sixty‐nine per cent of positive biopsies contained HPV 16, 18, 31 and 33. HPV 6 and 11 were found only in condylomata acuminata samples. Conclusions The results point to a high incidence of HPV infection as well as of CIN in HIV‐positive patients. Human papillomavirus type 16 appears to be most frequently associated with CIN. Polymerase chain reaction‐ISH is more sensitive than ISH in the detection and typing of HPV DNA both in clinical and in ‘latent’ infections. The two techniques yielded the same results with either formalin‐ or Bouin's‐fixed material.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here